文献速递脑血管病

赢率法在卒中试验分析中的应用:描述、示例及在第二项欧洲颈动脉外科试验(ECST-2)中的计划使用

Use of the Win Ratio for Analysis of Stroke Trials: Description, Illustration, and Planned Use in the Second European Carotid Surgery Trial (ECST-2).
PubMed 文献 · Stroke · 2024-10-02

本文介绍赢率法作为卒中试验的替代分析方法,通过将复合终点按临床重要性分层来优先考虑重要结局。利用ICSS和MR CLEAN两项试验数据示例说明,赢率法可强调最重要结局、整合不同结局类型并自然处理死亡竞争风险。赢率法将用于ECST-2试验的分层主要结局分析,作者推荐在未來卒中试验中更广泛应用。

要点

  • 赢率法将复合终点按临床重要性分层,优先考虑重要结局。
  • 赢率法可整合不同结局类型并自然处理死亡竞争风险。
  • 赢率法将用于ECST-2试验的分层主要结局分析。

核心结论

  • 赢率法为分析试验结局提供了有用的临床相关方法,相比传统方法具有优势,作者推荐在未來卒中试验中更广泛应用。

研究设计与样本

  • 本文为方法学描述与示例文章,利用ICSS和MR CLEAN两项试验的数据说明赢率法的应用。

主要发现

  • 赢率法的潜在益处包括:强调临床最重要的结局;将不同结局类型(如时间-事件、连续和分类变量)整合为复合终点;在定量结局分析中自然处理死亡竞争风险。

关键数值与推荐

  • ECST-2试验的分层主要结局为:围手术期死亡、致死性卒中或致死性心肌梗死的时间(最重要);非致死性卒中的时间;非致死性心肌梗死的时间(排除静息性梗死);脑影像学上新发静息性脑梗死(最不重要)。

临床怎么用

  • 赢率法将用于ECST-2试验的分层主要结局分析。
  • 作者建议在未來卒中试验中更广泛应用赢率法。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Randomized trials in stroke often focus on outcomes beyond a single clinical event. Trials of stroke prevention commonly use composite outcomes that include multiple components (eg, death, stroke, or myocardial infarction). A major limitation is that all events count equally but may differ markedly in terms of clinical severity. Trials in acute stroke often use ordinal outcomes or scale scores. Limitations include the requirement for statistical assumptions and the difficulty of handling the competing risk of death. We introduce the win ratio as an alternative method. It works by placing components of a composite into a hierarchy, whereby clinically more important outcomes take priority over less important ones. We illustrate how it works using data from 2 major stroke trials: the ICSS (International Carotid Stenting Study, a trial in stroke prevention) and the MR CLEAN (Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands). Potential benefits of the win ratio approach include the possibility to (1) emphasize the clinically most important outcomes, (2) combine components of different outcome types into a composite (eg, a mixture of time-to-event, continuous, and categorical), and (3) naturally handle the competing risk of death in analyses of quantitative outcomes. The win ratio will be used in the upcoming analysis of the ECST-2 (Second European Carotid Surgery Trial), which has a hierarchical primary outcome of (1) time to perioperative death, fatal stroke, or fatal myocardial infarction (most important); (2) time to nonfatal stroke; (3) time to nonfatal myocardial infarction (excluding silent infarcts); and (4) new silent cerebral infarct on brain imaging (least important). The win ratio provides a useful clinically relevant method for analyzing trial outcomes. It has some advantages over conventional methods, and we recommend its wider application in future stroke trials.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Gregson J, Donners SJA, Dippel D, et al. Use of the Win Ratio for Analysis of Stroke Trials: Description, Illustration, and Planned Use in the Second European Carotid Surgery Trial (ECST-2). Stroke. 2024. PMID: 39355921. doi:10.1161/STROKEAHA.124.048689

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。